Lung Cancer

ASCO Annual Meeting, held in person for the first time since 2019 due to the COVID-19 pandemic, took place June 3-7 in Chicago.

Obesity appeared associated with improved immunotherapy outcomes among patients with certain cancer types, according to a cohort study published in JAMA Network Open.

CHICAGO — Acetaminophen suppressed antitumor immunity in a cohort of patients with cancer, according to study results presented during ASCO Annual Meeting.

CHICAGO — Adagrasib demonstrated promising efficacy for pretreated patients with advanced or metastatic non-small cell lung cancer who harbor KRASG12C mutations, according to study results presented at ASCO Annual Meeting.

Both visual and quantitative CT assessments of emphysema were associated with greater odds of lung cancer, researchers reported in Radiology.

CHICAGO — During the ASCO Annual Meeting, Healio honored our inaugural Healio Disruptive Innovators in hematology/oncology.

CHICAGO — A new combination therapy benefitted certain patients with immunotherapy-resistant advanced non-small cell lung cancer, according to randomized phase 2 study results presented at ASCO Annual Meeting.

Charu Aggarwal, MD, MPH, shared with Healio non-small cell lung cancer studies she is most looking forward to seeing the results of at the ASCO Annual Meeting, taking place June 3-7 in Chicago.

The inclusion of a smoking cessation tool into electronic health records increased self-reported patient quit rates by more than 5 percentage points, according to study results.

In this video, Hina Khan, MD, shares what lung cancer studies and networking opportunities she is looking forward to the most at the ASCO Annual Meeting, taking place June 3-7 in Chicago.